Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FTRE NYSE:TDOC NASDAQ:VMD NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFTREFortrea$19.52+0.1%$16.42$5.26▼$20.19$1.85B2.031.19 million shs1.34 million shsTDOCTeladoc Health$8.72+0.7%$8.05$4.40▼$9.89$1.58B2.14.28 million shs4.35 million shsVMDViemed Healthcare$11.77+0.9%$10.90$5.93▼$12.61$451.23M1.1325,506 shs228,715 shsWGSGeneDx$59.10-6.8%$58.75$32.21▼$170.87$1.75B1.9685,940 shs429,445 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFTREFortrea0.00%+9.91%+10.22%+99.18%+209.35%TDOCTeladoc Health0.00%-7.44%+10.49%+50.79%+1.98%VMDViemed Healthcare0.00%-3.13%+0.68%+21.84%+82.20%WGSGeneDx0.00%-6.90%-13.94%-13.76%-28.75%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFTREFortrea$19.52+0.1%$16.42$5.26▼$20.19$1.85B2.031.19 million shs1.34 million shsTDOCTeladoc Health$8.72+0.7%$8.05$4.40▼$9.89$1.58B2.14.28 million shs4.35 million shsVMDViemed Healthcare$11.77+0.9%$10.90$5.93▼$12.61$451.23M1.1325,506 shs228,715 shsWGSGeneDx$59.10-6.8%$58.75$32.21▼$170.87$1.75B1.9685,940 shs429,445 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFTREFortrea0.00%+9.91%+10.22%+99.18%+209.35%TDOCTeladoc Health0.00%-7.44%+10.49%+50.79%+1.98%VMDViemed Healthcare0.00%-3.13%+0.68%+21.84%+82.20%WGSGeneDx0.00%-6.90%-13.94%-13.76%-28.75%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFTREFortrea 2.55Moderate Buy$17.75-9.07% DownsideTDOCTeladoc Health 2.25Hold$7.57-13.20% DownsideVMDViemed Healthcare 2.00HoldN/AN/AWGSGeneDx 2.56Moderate Buy$87.4347.93% UpsideCurrent Analyst Ratings BreakdownLatest VMD, WGS, TDOC, and FTRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/21/2026TDOCTeladoc Health Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$10.00 ➝ $11.007/17/2026FTREFortrea Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)7/17/2026VMDViemed Healthcare Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)7/15/2026WGSGeneDx TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy7/13/2026FTREFortrea MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$13.00 ➝ $16.007/7/2026TDOCTeladoc Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$9.00 ➝ $10.507/6/2026FTREFortrea Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy6/29/2026WGSGeneDx GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$70.00 ➝ $74.006/29/2026WGSGeneDx Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell6/24/2026FTREFortrea BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$16.00 ➝ $18.006/23/2026WGSGeneDx Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$50.00 ➝ $63.00(Data available from 7/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFTREFortrea$2.72B0.68$9.91 per share1.97$6.10 per share3.20TDOCTeladoc Health$2.53B0.62$1.79 per share4.87$7.81 per share1.12VMDViemed Healthcare$270.28M1.67$1.15 per share10.22$3.78 per share3.11WGSGeneDx$427.54M4.10$2.29 per share25.78$10.54 per share5.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFTREFortrea-$986.20M-$4.91N/A19.920.59-16.50%9.51%1.96%7/29/2026 (Estimated)TDOCTeladoc Health-$200.32M-$0.97N/AN/AN/A-6.81%-11.45%-5.54%7/29/2026 (Estimated)VMDViemed Healthcare$14.93M$0.3731.8120.29N/A5.20%10.52%7.60%8/3/2026 (Estimated)WGSGeneDx-$21.02M-$2.68N/A67.93N/A-17.58%9.15%5.21%8/3/2026 (Confirmed)Latest VMD, WGS, TDOC, and FTRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/3/2026Q2 2026VMDViemed Healthcare$0.10N/AN/AN/A$78.00 millionN/A8/3/2026Q2 2026WGSGeneDx-$0.19N/AN/AN/A$111.01 millionN/A7/29/2026Q2 2026FTREFortrea$0.18N/AN/AN/A$647.53 millionN/A7/29/2026Q2 2026TDOCTeladoc Health-$0.24N/AN/AN/A$615.45 millionN/A5/5/2026Q1 2026FTREFortrea$0.03$0.16+$0.13-$0.25$628.51 million$636.50 million5/5/2026Q1 2026VMDViemed Healthcare$0.09$0.06-$0.03$0.06$74.40 million$75.41 million5/4/2026Q1 2026WGSGeneDx-$0.06-$0.28-$0.22-$2.16$112.46 million$102.25 million4/29/2026Q1 2026TDOCTeladoc Health-$0.3454-$0.36-$0.0147-$0.36$611.04 million$613.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthFTREFortreaN/AN/AN/AN/AN/ATDOCTeladoc HealthN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFTREFortrea1.980.950.95TDOCTeladoc Health0.752.802.72VMDViemed Healthcare0.061.221.10WGSGeneDx0.383.092.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFTREFortreaN/ATDOCTeladoc Health76.82%VMDViemed Healthcare74.24%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipFTREFortrea0.73%TDOCTeladoc Health0.70%VMDViemed Healthcare20.60%WGSGeneDx25.17%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFTREFortrea14,30094.60 million93.91 millionOptionableTDOCTeladoc Health5,600180.51 million179.25 millionOptionableVMDViemed Healthcare1,38238.34 million30.44 millionNot OptionableWGSGeneDx1,30029.69 million22.22 millionOptionableVMD, WGS, TDOC, and FTRE HeadlinesRecent News About These CompaniesWGS 9-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff DeadlineJuly 25 at 8:06 PM | globenewswire.comWGS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026July 25 at 6:40 AM | newsfilecorp.comNGeneDx Holdings Corp. $WGS Shares Purchased by Granahan Investment Management LLCJuly 25 at 6:31 AM | marketbeat.comGeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGSJuly 24 at 10:00 PM | prnewswire.comGeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLCJuly 24 at 5:21 PM | newsfilecorp.comNWGS 10-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff DeadlineJuly 24 at 2:37 PM | globenewswire.comAUGUST 3, 2026 WGS DEADLINE ALERT: Robbins Geller Rudman & Dowd LLP Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitJuly 24 at 2:10 PM | globenewswire.comWGS UPCOMING DEADLINE : The Gross Law Firm Alerts GeneDx Holdings Corp. Stockholders of Securities Class Action - Contact the FirmJuly 24 at 1:19 PM | globenewswire.comBronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor HarmJuly 24 at 12:00 PM | newsfilecorp.comNINVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJuly 24 at 8:45 AM | prnewswire.comHAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff DeadlineJuly 24 at 8:00 AM | prnewswire.comWGS Deadline: Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their RightsJuly 23 at 8:25 PM | lasvegassun.comLWGS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026July 23 at 8:22 PM | newsfilecorp.comNWGS Deadline: Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their RightsJuly 23 at 3:14 PM | businesswire.comWGS FINAL DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGSJuly 23 at 3:13 PM | globenewswire.comGeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGSJuly 23 at 11:52 AM | globenewswire.comLost Money on GeneDx Holdings Corp. (WGS)? Join Class Action Suit Seeking Recovery - Contact SueWallStJuly 23 at 10:09 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines - WGSJuly 23 at 10:00 AM | prnewswire.comWGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law FirmJuly 23 at 9:47 AM | globenewswire.comWGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- August 3, 2026 DeadlineJuly 22, 2026 | prnewswire.comWGS Deadline: WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud LawsuitJuly 22, 2026 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVMD, WGS, TDOC, and FTRE Company DescriptionsFortrea NASDAQ:FTRE$19.52 +0.02 (+0.10%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$19.96 +0.45 (+2.28%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Teladoc Health NYSE:TDOC$8.72 +0.06 (+0.73%) Closing price 07/24/2026 03:59 PM EasternExtended Trading$8.75 +0.03 (+0.31%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.Viemed Healthcare NASDAQ:VMD$11.77 +0.10 (+0.86%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$11.76 -0.01 (-0.13%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.GeneDx NASDAQ:WGS$59.10 -4.28 (-6.75%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$59.00 -0.10 (-0.17%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
